301
Views
3
CrossRef citations to date
0
Altmetric
Drug Evaluation

Bisoprolol for congestive heart failure

, MD & , MD PhD
Pages 293-300 | Published online: 17 Jan 2008
 

Abstract

Background: β-Blockers are a cornerstone in the treatment of systolic heart failure treatment, but not all β-blockers are effective or in this setting. Objective: To define the role of bisoprolol, a highly selective β1-antagonist in congestive heart failure due to systolic dysfunction. Methods: Using the keywords ‘bisoprolol’ and ‘heart failure’ PubMed and BIOSIS databases were searched for information regarding pharmacology and relevant randomised clinical trials. Supplementary publications were acquired by scrutinising reference lists of relevant papers. Additional information was obtained from the FDA website. Conclusion: Bisoprolol is an effective and well-tolerated first-line β-blocker for patients with systolic heart failure. The knowledge is primarily based on study patients with moderate-to-severe heart failure from the three CIBIS trials.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.